Clinical Trial Update: Natural Killer Cell Therapy (UD TGFbetai NK Cells) and Temozolomide for the Treatment of Stage IV Melanoma Metastatic to the Brain [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial is evaluating natural killer cell therapy (UD TGFβi NK cells) in combination with temozolomide for patients with stage IV cutaneous m…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases
• Cutaneous Melanoma

Drugs mentioned

• Temodar (Temozolomide)
• UD TGFβi NK Cells

Snippet

Sponsor: Kari Kendra | Conditions: Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Malignant Neoplasm in the Brain | Phase 1, Phase 2 | Status: RECRUITING